WebMD's guide to the meningococcal vaccine, who needs it, when it is given, and possible side effects.

GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage recommendations on Feb. 26.

Penmenvy is a combination of antigens from GSK's established vaccines: Bexsero (Meningococcal Group B vaccine) and Menveo (Meningococcal [Groups A, C, Y, and W-135] Oligosaccharide Diphtheria ...

Bexsero (meningococcal group B) is a vaccine used to prevent meningitis B. Bexsero can cause side effects that range from mild to serious. Examples include injection site redness and pain, muscle ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

Bexsero (meningococcal group B vaccine) is a vaccine that’s used to prevent meningitis B. It comes in a prefilled syringe for injection into a muscle. It’s given as two doses at least 1 month ...

Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to play catch-up after nabbing its own FDA approval. | The company's ...

Bexsero (meningococcal group B vaccine) is a vaccine used to prevent meningitis B. Bexsero comes as a prefilled syringe for injection by a healthcare professional. It’s given as two doses at ...

The MenABCWY vaccine combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM 197 conjugate ...

A vaccination campaign against meningococcal B bacteria has been initiated in the Chambéry and Lyon-East regions of France following an increase in infections with a new variant.

Complete vaccination with the four-component, protein-based meningococcal serogroup B vaccine (4CMenB; Bexsero) was found to be effective in the prevention of invasive serogroup B and non ...